SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001493152-17-003796
Filing Date
2017-04-13
Accepted
2017-04-12 17:43:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 sc13g.htm SC 13G 83931
  Complete submission text file 0001493152-17-003796.txt   85227
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Subject) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE
Type: SC 13G | Act: 34 | File No.: 005-81115 | Film No.: 17758778
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3 PHEASANT RUN SETAUKET NY 11733
Business Address
Bahl Lalit Rai (Filed by) CIK: 0001703504 (see all company filings)

Type: SC 13G